Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Barbara Wirostko currently holds 403,893 shares of EYEGATE PHARMACEUTICALS INC (EYEG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Wirostko has been a net seller of EYEG stock. They have purchased $0 and sold $4.6K worth of shares.
Barbara Wirostko's most recent insider trade was on Aug 6, 2019, when they sold 1,641 shares at $0.21 per share.
Barbara Wirostko serves as Executive at EYEGATE PHARMACEUTICALS INC (EYEG). They have executed 18 insider transactions totaling $4.6K over their tenure at the company.
Barbara Wirostko holds the position of Executive at EYEGATE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Barbara Wirostko has shown a selling trading pattern, with $0 in total purchases and $4.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Barbara Wirostko was on Feb 28, 2017, when they purchased $140.4K worth of EYEG shares. This transaction involved 54,200 shares at $2.59 per share.
Barbara Wirostko currently owns 403,893 shares of EYEGATE PHARMACEUTICALS INC (EYEG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Barbara Wirostko's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barbara Wirostko has 18 Form 4 filings on record as an insider at EYEGATE PHARMACEUTICALS INC.
Set alerts for Barbara Wirostko and 40,000+ other insiders.